Find Resources and Support - National Multiple Sclerosis Society

Skip to navigation Skip to content

Find Resources and Support

The Society offers many programs and services to help people affected by MS live their best lives. Find resources in your area to learn, connect, and get support.

Filter
        
Categories
  1. VIDEO Clinical Trials

    Clinical Trials: Solving One Piece of the MS Puzzle Part 1 (video)

    This video features part one of a series that discusses research efforts for multiple sclerosis and clinical trials.

  2. ONLINE Clinical Trials

    Clinical Trials in MS

    Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

  3. ONLINE Clinical Trials

    Find Clinical Trials

    Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

  4. ONLINE Clinical Trials

    From Clinical Trials to Treatments

    This presentation is: From Clinical Trials to Treatments.

  5. ONLINE Clinical Trials

    Symptomatic Treatment Trials

    This document outlines Symptomatic Treatment Trials.

  6. IN PERSON Clinical Trials

    LINGO-1

    A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of Multiple Sclerosis When Used Concurrently with Avonex® (215MS201, SYNERGY)

    St. Louis, MO 63110See Map
  7. IN PERSON Clinical Trials

    215MS301, ALLOW

    An Open-Label, Two-Arm, Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning from Current Interferon Beta Therapies to BIIB017 (215MS301, ALLOW)

    St. Louis, MO 63110See Map
  8. IN PERSON Clinical Trials

    ASSESS

    A 12 month, dose-blinded study that compares the safety and effectiveness of 0.25 and 0.5 mg daily oral fingolimod with daily subcutaneous injection of 20 mg glatiramer acetate (Copaxone) in patients with Relapsing Remitting MS.

    St. Louis, MO 63017See Map
  9. IN PERSON Clinical Trials

    ALLOW

    A study to describe efficacy, tolerability and convenience of teriflunomide (Aubagio) treatment using PROs (Patient Reported Outcomes) in RMS (Relapsing MS) patients.

    St. Louis, MO 63017See Map
  10. IN PERSON Clinical Trials

    ASSESS MS Study: FTY720D2312

    A 12-month, randomized, rater-and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis.

Share